Historical Stock Price
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| RARE Historical Stock Prices |
| Preferred Stock Newsletter |
| RARE Options Chain |
| Stock Message Boards |
Ultragenyx Pharmaceutical (RARE) has the following price history information. Looking back at RARE historical stock prices for the last five trading days, on April 18, 2024, RARE opened at $44.10, traded as high as $44.80 and as low as $43.32, and closed at $43.38. Trading volume was a total of 768.20K shares. On April 19, 2024, RARE opened at $43.26, traded as high as $43.92 and as low as $41.07, and closed at $42.37. Trading volume was a total of 676.10K shares. On April 22, 2024, RARE opened at $43.23, traded as high as $44.44 and as low as $42.40, and closed at $43.69. Trading volume was a total of 592.40K shares. On April 23, 2024, RARE opened at $43.74, traded as high as $45.58 and as low as $43.13, and closed at $45.11. Trading volume was a total of 836.70K shares. On April 24, 2024, RARE opened at $45.52, traded as high as $45.55 and as low as $43.61, and closed at $44.28. Trading volume was a total of 670.60K shares.
RARE Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Ultragenyx Pharmaceutical shares, starting with a $10,000 purchase of RARE, and working forward through the historical stock price information to today.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 04/28/2014 | |
| End date: | 04/24/2024 | |
| Start price/share: | $36.84 | |
| End price/share: | $44.28 | |
| Dividends collected/share: | $0.00 | |
| Total return: | 20.20% | |
| Average Annual Total Return: | 1.86% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $12,023.05 | |
| Years: | 10.00 | |
 | |||||
| RARE Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 04/18/2024 | $44.10 | $44.80 | $43.32 | $43.38 | 768.20K |
| 04/19/2024 | $43.26 | $43.92 | $41.07 | $42.37 | 676.10K |
| 04/22/2024 | $43.23 | $44.44 | $42.40 | $43.69 | 592.40K |
| 04/23/2024 | $43.74 | $45.58 | $43.13 | $45.11 | 836.70K |
| 04/24/2024 | $45.52 | $45.55 | $43.61 | $44.28 | 670.60K |
|
| About Ultragenyx Pharmaceutical |
| Ultragenyx Pharmaceutical is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of products for the treatment of genetic diseases. Co. has four commercially approved products, Crysvita® (burosumab) for the treatment of X-linked hypophosphatemia and tumor-induced osteomalacia, Mepsevii® (vestronidase alfa) for the treatment of mucopolysaccharidosis VII, or Sly Syndrome, Dojolvi® (triheptanoin) for the treatment of long-chain fatty acid oxidation disorders, and Evkeeza® (evinacumab) for the treatment of homozygous familial hypercholesterolemia. |
| RARE Historical Closing Prices | |
| Date | Close |
| 04/18/2024 | $43.38 |
| 04/19/2024 | $42.37 |
| 04/22/2024 | $43.69 |
| 04/23/2024 | $45.11 |
| 04/24/2024 | $44.28 |
| Healthcare Historical Prices |
| RARE is categorized under the Healthcare sector; below are some other companies in the same sector:
RARX Historical Stock Prices Also explore: RARE shares outstanding history
|
Free RARE Email Alerts:
RARE Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.